# Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis

> **NCT03092154** · NA · TERMINATED · sponsor: **University of Sao Paulo** · enrollment: 24 (actual)

## Conditions studied

- Treatment Side Effects

## Interventions

- **DRUG:** Lipid-lowering agents (Artovastatin)

## Key facts

- **NCT ID:** NCT03092154
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01
- **Primary completion:** 2022-05-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03092154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03092154, "Lipid-lowering Agents in Patients With Dermatomyositis and Polymyositis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03092154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*